Ketamine-assisted psychotherapy, psychedelic methodologies, and the impregnable value of the subjective—a new and evolving approach
Frontiers in Psychiatry February 1, 2024 DOI: 10.3389/fpsyt.2024.1209419 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Theoretical or philosophical paper Peer reviewed |
|---|---|
| Intervention | Ketamine-assisted psychotherapy |
| Dose | subanesthetic doses |
| Topics | Ketamine Psilocybin Esketamine Psychedelic-assisted therapy |
| Keywords | Dissociative Consciousness Psychotherapist Hallucinogen |
| Citations | 17 |
| Key points | Proposes that ketamine's dissociative effects are not side effects but essential to its therapeutic impact, especially when embedded in a supportive therapeutic setting. |
Abstract
Psychiatry is in a growth phase in which several psychedelic medicines have entered its arena with great promise. Of these, presently, ketamine is the only medicine that may be legally prescribed. We hypothesize that at subanesthetic doses, ketamine produces a unique spectrum of altered states, ranging from psychoactive to deep ego-dissolving experiences, that are intrinsic to ketamine’s therapeutic effects. When these experiences are embedded in a therapeutic relationship—a setting—that fosters an amplification of the recipient’s subjective consciousness, personal growth, inner healing, greater clarity, and better relationships may well ensue. While much of the literature on ketamine labels its dissociative effects as ‘side effects’, alteration of consciousness is a component and unavoidable ‘effect’ of its therapeutic impact. From its inception in the clinical trials of the 1960s, ketamine was recognized for producing dissociative, psychedelic effects on consciousness in subjects as they emerged from ketamine-induced anesthesia. Unanticipated and unintegrated, these experiences of ‘emergence phenomena’ were felt to be disturbing. Accordingly, such experiences have been typically labeled as dissociative side effects. However, in a conducive set and settings, these experiences have been demonstrated to be of positive use in psychiatry and psychotherapy, providing a time-out from usual states of mind to facilitate a reshaping of self-experience along with symptomatic relief. In this way, ketamine-assisted psychotherapy (KAP) offers a new potential in psychiatry and psychotherapy that is powerfully valanced toward recognizing experience, individuality, and imagination. Essential to a successful therapeutic experience and outcome with KAP is close attention to the subjective experience, its expression by the recipient and integration of the ketamine experience as a healing opportunity.
In the evidence
This study is part of the evidence base for a synthesis in the library. Here is how each one recorded it.
-
Argues that ketamine's dissociative and ego-dissolving effects are intrinsic to its therapeutic action rather than side effects, especially within a supportive therapeutic setting.
Synthesized
Comparable studies
Other theoretical and historical papers on ketamine and psychedelic-assisted therapy, most cited first.
| Study | Year | Design | Participants |
|---|---|---|---|
| “Angry at the Wrong Thing:” Queering Ketamine Assisted Psychotherapy for Clients Experiencing Body Image and Eating Distress | 2024 | Theoretical or philosophical paper | |
| Making Play Safe Again: Ketamine-Assisted Psychotherapy with Traumatized Autistic Adults | 2026 | Theoretical or philosophical paper | |
| Dance of the four bodies: an enactive-individuative approach to ketamine assisted psychotherapy | 2026 | Theoretical or philosophical paper |
Citations in the library
Cited by 16
- Early psilocybin intervention alleviates behavioral despair and cognitive impairment in stressed Wistar rats Progress in Neuro-Psychopharmacology and Biological Psychiatry 2025
- Expert recommendations for Germany’s integration of psychedelic-assisted therapy BMC Medical Education October 24, 2024
- Psychedelic-Assisted Therapies for Psychosocial Symptoms in Cancer: A Systematic Review and Meta-Analysis Current Oncology June 30, 2025
- Ethical issues with psychedelic-assisted treatments in psychiatry: A systematic scoping review Psychological Medicine 2025
- Psychedelics and psychoanalysis: The journey from talking cure to transformation Journal of Psychedelic Studies August 21, 2024
and 11 more in the library
Cites 57
- A Randomized Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Major Depression Archives of General Psychiatry August 1, 2006
- Psychedelics Promote Structural and Functional Neural Plasticity Cell Reports June 1, 2018
- Measurement of dissociative states with the Clinician‐Administered Dissociative States Scale (CADSS) Journal of Traumatic Stress 1998
- The effect of a single dose of intravenous ketamine on suicidal ideation: a systematic review and individual participant data meta-analysis American Journal of Psychiatry October 3, 2017
- The Therapeutic Potential of Psychedelic Drugs: Past, Present, and Future. Neuropsychopharmacology April 26, 2017
and 52 more in the library